251 related articles for article (PubMed ID: 26825886)
1. Significant Effect of Valproate Augmentation Therapy in Patients With Schizophrenia: A Meta-analysis Study.
Tseng PT; Chen YW; Chung W; Tu KY; Wang HY; Wu CK; Lin PY
Medicine (Baltimore); 2016 Jan; 95(4):e2475. PubMed ID: 26825886
[TBL] [Abstract][Full Text] [Related]
2. Valproate as an adjunct to antipsychotics for schizophrenia: a systematic review of randomized trials.
Basan A; Kissling W; Leucht S
Schizophr Res; 2004 Sep; 70(1):33-7. PubMed ID: 15246461
[TBL] [Abstract][Full Text] [Related]
3. Valproate for schizophrenia.
Wang Y; Xia J; Helfer B; Li C; Leucht S
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD004028. PubMed ID: 27884042
[TBL] [Abstract][Full Text] [Related]
4. Valproate for schizophrenia.
Basan A; Leucht S
Cochrane Database Syst Rev; 2004; (1):CD004028. PubMed ID: 14974054
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Valproate for schizophrenia.
Schwarz C; Volz A; Li C; Leucht S
Cochrane Database Syst Rev; 2008 Jul; (3):CD004028. PubMed ID: 18646098
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
Gobbi G; Gaudreau PO; Leblanc N
J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186
[TBL] [Abstract][Full Text] [Related]
8. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
9. Lithium for schizophrenia.
Leucht S; Helfer B; Dold M; Kissling W; McGrath JJ
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003834. PubMed ID: 26509923
[TBL] [Abstract][Full Text] [Related]
10. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
Dold M; Samara MT; Li C; Tardy M; Leucht S
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299
[TBL] [Abstract][Full Text] [Related]
11. Early Non-Response to Antipsychotic Treatment in Schizophrenia: A Systematic Review and Meta-Analysis of Evidence-Based Management Options.
Rubio JM; Guinart D; Kane JM; Correll CU
CNS Drugs; 2023 Jun; 37(6):499-512. PubMed ID: 37261669
[TBL] [Abstract][Full Text] [Related]
12. Lithium or Valproate Adjunctive Therapy to Second-generation Antipsychotics and Metabolic Variables in Patients With Schizophrenia or Schizoaffective Disorder.
Vincenzi B; Greene CM; Ulloa M; Parnarouskis L; Jackson JW; Henderson DC
J Psychiatr Pract; 2016 May; 22(3):175-82. PubMed ID: 27123797
[TBL] [Abstract][Full Text] [Related]
13. Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach.
Glick ID; Correll CU; Altamura AC; Marder SR; Csernansky JG; Weiden PJ; Leucht S; Davis JM
J Clin Psychiatry; 2011 Dec; 72(12):1616-27. PubMed ID: 22244023
[TBL] [Abstract][Full Text] [Related]
14. Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials.
Zheng W; Xiang YT; Yang XH; Xiang YQ; de Leon J
J Clin Psychiatry; 2017 May; 78(5):e498-e505. PubMed ID: 28355041
[TBL] [Abstract][Full Text] [Related]
15. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Stip E; Tourjman V
Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
[TBL] [Abstract][Full Text] [Related]
16. Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials.
Dold M; Li C; Gillies D; Leucht S
Eur Neuropsychopharmacol; 2013 Sep; 23(9):1023-33. PubMed ID: 23602690
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: a meta-analysis of double-blind randomized placebo-controlled trials.
Kishi T; Mukai T; Matsuda Y; Moriwaki M; Iwata N
J Psychiatr Res; 2013 Nov; 47(11):1557-63. PubMed ID: 23899496
[TBL] [Abstract][Full Text] [Related]
18. Benzodiazepines for schizophrenia.
Dold M; Li C; Tardy M; Khorsand V; Gillies D; Leucht S
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD006391. PubMed ID: 23152236
[TBL] [Abstract][Full Text] [Related]
19. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients.
Ventriglio A; Vincenti A; Centorrino F; Talamo A; Fitzmaurice G; Baldessarini RJ
Int Clin Psychopharmacol; 2011 Mar; 26(2):88-95. PubMed ID: 21030870
[TBL] [Abstract][Full Text] [Related]
20. Results of a naturalistic study of treatment options: switching atypical antipsychotic drugs or augmenting with valproate.
Cramer JA; Sernyak M
Clin Ther; 2004 Jun; 26(6):905-14. PubMed ID: 15262461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
